Early Detection
Early Detection-ELSA Seq Methylation Based Multi-Cancer Early Detection Assay

Lung, colorectal, liver, ovarian, pancreatic, esophageal, gastric, cholangio, head and neck

3 -> 6 -> 9 cancer

~80% sensitivity @ 98% specificity

Performance comparable to Grail’s assay (outperformed on lung and colorectal)

Can be used to supplement at risk screening (For example: colonoscopy)

Improve early detection and improve patient outcomes

